key: cord-0903367-ikxf483h
authors: Elhabyan, Abdelazeem; El Yaacoub, Saja; Sanad, Ehab; Mohamed, Abdelwahab; Elhabyan, Asmaa; Dinu, Valentin
title: The role of Host Genetics in susceptibility to severe viral infections in humans and INSIGHTS into host genetics of severe COVID-19: A systematic review
date: 2020-09-09
journal: Virus Res
DOI: 10.1016/j.virusres.2020.198163
sha: 476003e3559ac4504f2aeea0e2604d245af64bd5
doc_id: 903367
cord_uid: ikxf483h

BACKGROUND: Susceptibility to severe viral infections was reported to be associated with genetic variants in immune response genes using case reports and GWAS studies. SARS-CoV-2 is an emergent viral disease that caused millions of COVID-19 cases all over the world. Around 15% of cases are severe and some of them are accompanied by dysregulated immune system and cytokine storm. There is increasing evidence that severe manifestations of COVID-19 might be attributed to human genetic variants in genes related to immune deficiency and or inflammasome activation (cytokine storm). OBJECTIVE: Identify the candidate genes that are likely to aid in explaining severe COVID-19 and provide insights to understand severe COVID-19. METHODS: In this article, we systematically reviewed genes related to viral susceptibility that were reported in human genetic studies (Case reports and GWAS) to understand the role of host viral interactions and to provide insights into the pathogenesis of severe COVID-19. RESULTS: We found 40 genes associated with viral susceptibility and 21 of them were associated with severe SARS-CoV disease and severe COVID-19. Some of those genes were implicated in TLR pathways, others in C-lectin pathways, and others were related to inflammasome activation (cytokine storm). CONCLUSIONS: This compilation represents a list of candidate genes that are likely to aid in explaining severe COVID-19 which are worthy of inclusion in gene panels and during meta-analysis of different variants in host genetics studies of COVID-19. In addition, we provide several hypotheses for severe COVID-19 and possible therapeutic targets.

In late 2019, a novel respiratory disease caused by a novel coronavirus was identified in China now named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)("Archived:

WHO Timeline -COVID-19," 2020). By August 2020, the COVID-19 (Coronavirus Disease-J o u r n a l P r e -p r o o f 2019) pandemic caused more than 20 million confirmed infections and more than 700000 deaths Situation Report -205, 2020) . Most of COVID-19 cases are mild, while about 15% develop severe disease that results in acute respiratory distress syndrome associated with dysregulated immune response, systemic inflammation and cytokine storm. Host genetic factors predisposing to severe viral infection include inborn errors of immunity which involve a single genetic mutation that predisposes to a certain type of infection, e.g., single viral infection as reported in the International Union of Immunological Societies (IUIS) list of human inborn errors of immunity (Tangye et al., 2020) . Additionally, viral susceptibility, like other polygenic diseases, can be determined by single nucleotide polymorphisms (SNPs) in genes that are involved in the immune response to viral infection with different allele frequencies and effect sizes. Those SNPs can be identified through Genome-Wide Association Studies (GWAS) (Cao et al., 2009) (Hamano et al., 2005) (He et al., 2006) (Manolio et al., 2009) . Our systematic review includes both types of studies (Case report studies for inborn errors of immunity and GWAS studies).

Immune response to SARS-CoV-2 can be divided into two phases. In the first phase, the body tries to eliminate the virus using regulated immune response in the early asymptomatic and nonsevere disease stages, preventing progression to the severe stage. In the second phase, there is an inflammatory cytokine storm and hyper-activation of the immune system leading to severe disease and death in some cases (Shi et al., 2020) . The high fatality rate of COVID-19 may be partly due to excessive production of cytokines and inflammatory mediators(cytokine storm) leading to a hyperactive non-productive immune state causing lung and other organs injury . We found little published data about the role of first phase of immune response where the body tries to eliminate the virus. Accordingly, we shed light on both phases of immune response to viral infections during our review.

As of August 12, 2020, there are more than 200 host genetics studieswith different study designstrying to identify possible associations between human genes and the prognosis of COVID-19 patients. Most of these studies are Genome-Wide Association Studies (GWAS) and depend on the association of genetic variations with different phenotypes such as severe COVID-19 disease ("The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic," 2020).It is essential for these investigators to have a list of candidate genes that are likely to be involved J o u r n a l P r e -p r o o f in COVID-19 pathogenesis. Genomics England used wide inclusion criteria to design a gene panel to investigate COVID-19. This panel includes nearly 500 genes associated with different immunological deficiencies in studies done on animals or humans (Martin et al., 2019) . In our review, we refine this panel and create a gene list of the most likely genes that might be involved in severe COVID-19 disease based on a set of criteria discussed below in the methods section.

These criteria include that our curated gene list contains only studies on humans and that genetic mutations predisposed to severe viral infections in otherwise healthy individuals (in case report studies) or predisposed to SARS-CoV or SARS-CoV-2 in GWAS studies providing the highest evidence for possible involvement in severe COVID-19 disease.

To our knowledge, there are no such systematic reviews dedicated to creating a catalog of host genes and genetic variants that confer susceptibility to severe viral infections in humans. Accordingly, we included different genes involved in both phases of the immune response to create a list of human genes and genetic variants that are highly likely to be associated with susceptibility to severe COVID-19 disease.

This gene list can benefit investigators in two ways: the first one is to make sure that those genes are present in gene panels used for host genetic studies as they are likely candidates of association with severe COVID-19 disease. The second one is to systematically evaluate evidence from different GWAS studies using meta-analysis for genetic variants on our gene list to increase the statistical power of evidence generated (Zeggini and Ioannidis, 2009 ). In addition, we provide new insights and different hypotheses for genes involved in severe COVID-19 disease based on our reviews of different viral susceptibility studies and briefly review the COVID-19 host genetics studies published up to this date.

We included two types of studies in our systematic review: case report and case-control GWAS studies.

For case report studies of inborn errors of immunity, we used the International Union of Immunological Society (IUIS) list which is a highly validated list by immunology experts including only studies with compelling evidence of pathogenic variants predisposing to infections (Tangye et al., 2020) . Next, we checked the OMIM database to find the related studies.

1. Gene and genetic variant associated with susceptibility to single or multiple viral infections in otherwise healthy individuals 2. Genetic variants associated with a severe or life-threatening viral infection 3. Multiple unrelated cases from different families with in vitro validation of the effect of pathogenic variant 4. Few or a single case with rigorous validation of the genetic defect using in vitro studies Exclusion Criteria 1. Genetic variants associated with long term outcomes as malignancy 2. Genetic variants which not rigorously validated using in vitro studies Two reviewers independently screened all the titles and abstracts to identify publications that are relevant. A third reviewer assessed the two independent lists of selected and rejected sources and made the final selection where there were discrepancies.

In each paper included in Table 1 and 

We reviewed case reports related to susceptibility to severe viral infections In general (Table 1) and GWAS studies related to susceptibility to severe infections of SARS-CoV or SARS-COV2 (Table 2) .We identified 40 genes that we expect to be highly involved in host genetic susceptibility to severe COVID-19, and hence deserve consideration during design and J o u r n a l P r e -p r o o f interpretation of case report and GWAS studies of COVID-19 and also during a meta-analysis of different GWAS studies. Table 3 below represents a brief version of our systematic review.

However, it does not substitute Table 1 and Table 2 (the complete version of our review), and we recommend that the reader refers to Table 1 and Table 2 during reading.

Several studies reported genetic mutations involved in the TLR3 signaling pathway including TLR3, TRIF, TRAF3, and TBK1 genes. In a recent study done on 16 patients with adult-onset

Herpes simplex encephalitis(HSE) using whole-exome sequencing (WES), 1 patient was discovered to have TLR3 deficiency, while the 8 other patients had mutations in other genes in the TLR3 signaling pathway(2 patients with a mutation in IRF3, 2 patients with mutations in STAT1, 2 patients with mutations in TRIF, 1 patient with a mutation in TYK2,1 patient with a mutation in MAVS, and finally 1 patient with a mutation in TBK1) (Mørk et al., 2015) .

The most associated gene with severe viral infections is TLR3 which is a receptor for doublestrand RNA, dsRNA (intermediate in the replication of many viruses which induces interferon(IFN)response to prevent the cytopathic effects of different viruses (Oshiumi et al., 2003) In some cases, a single gene (e.g., TLR3) was involved in predisposition to several viruses (Lim et al., 2019) (Zhang et al., 2007) and a single mutation (P554S) predisposed to different viral infections (HSE and ARDS due to IAV) which support our hypothesis of the possible involvement of our reviewed genes in COVID-19 susceptibility, and hence the need for a candidate gene list (Lim et al., 2019) (Zhang et al., 2007) . Additionally, Other mutations were reported in TLR7 or TLR9 pathways leading to impaired interferon 1 production (Kawasaki and Kawai, 2014) . Other mutations were reported in some interferon-stimulated genes (ISG) such as

MxA which inhibits intracellular trafficking of invading viruses and OAS-1 genes responsible for antiviral activity by inhibition of translation of viral proteins in addition to enhancing viral RNA degradation (Malterer et al., 2014) .

Lectin pathway is an alternative pathway for pathogen detection through the carbohydrate moiety expressed on the surface of different pathogens (e.g. glycoproteins of viruses). Upon binding to lectin receptors, pathogens are internalized into the cell, degraded by lysosomes to be presented on the MHC II to T cells (Van Kooyk and Geijtenbeek, 2003) . DC-SIGN (CD 209) (Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin) is a C-type lectin expressed on the surface of immature dendritic cells and macrophages in peripheral mucosal sites including alveolar macrophages (Tailleux et al., 2005) . Several studies proved the binding affinity of DC-SIGN to different viruses including SARS-CoV Spike glycoprotein (Van Kooyk and Geijtenbeek, 2003) (Marzi et al., 2004) . Recently, SARS-CoV-2 binding to DC-SIGN and macrophage galactose lectin (MGL) was identified as ACE2 independent binding method to human cells and lung microbiota (Chiodo et al., 2020) . Additionally, Polymorphisms of DC-SIGN were associated with a higher Lactate dehydrogenase (LDH) level in SARS-CoV patients ̶ LDH is a systemic marker of inflammation (Chan et al., 2010) . Moreover, Mannose-binding lectin was associated with SARS-CoV severity in patients (Zhang et al., 2005) . Accordingly, polymorphisms in C-lectin genes might explain severe COVID-19 disease.

Binding to DC-SING has been incriminated in the persistence of HIV infection in dendritic cells despite small viral loads. Instead of being degraded by lysosomes and presented to T-cells, HIV virus was able to survive inside dendritic cells under the cell membrane camouflaging the immune system (Kwon et al., 2002) (Geijtenbeek et al., 2000) . Consequently, we suggest dendritic cells might play the role of the safe house for SARS-CoV-2 explaining many cases of recurrent COVID-19 disease (Ravioli et al., 2020) (Loconsole et al., 2020) . inhibition as a possible treatment option for severe COVID-19 using the keywords "COVID-19" and "IL-18" in clinicaltrials.gov and found no registered clinical trials. Accordingly, we think that IL-18 inhibition can provide a therapeutic option in patients with severe COVID-19 disease. Accordingly, studying close family members is essential to understand the penetrance of the suspected mutation and the inheritance pattern which can help us in prevention and prediction of severe COVID-19 disease in susceptible relatives of patients.

On one hand, GWAS studies included patients from different age groups. On the other hand, almost all case report studies we reviewed were on children with a single study on old age population (Mørk et al., 2015) ,and this can be explained by the tendency to attribute unexpected severe manifestations in otherwise healthy young individuals to monogenic factors ( single-gene disorders of inborn errors of immunity).

Surprisingly, we did not find any case report studies on healthy young population between the age of 18 and 50. Hence, we invite researchers to widen their inclusion criteria to include this age group in case report studies as most of them are healthy without preexisting conditions to confound the genetic theory of their susceptibility to severe COVID-19.

Countries of origin were diverse(as demonstrated in table 1 and table 2) with most case report studies from European countries while GWAS studies included Japanese, Chinese, and

Vietnamese among other eastern populations and this can be explained by the wide spread of SARS-CoV in China and Eastern countries (Zhong et al., 2003) . Case report studies as a study design for COVID-19 host genetics studies. . In this model of case report study, we are investigating the direct causal relationship between a single genetic mutation and severe clinical manifestations.

Statistical methods are essential to compare genetic variants in those patients with a matched control (e.g. general population or other family members who tested positive without severe manifestation or complication from COVID-19). On evaluation of potential genes suspected for causing clinical manifestation, investigators should start with previously implicated genes in the same phenotypes before investigating potential new genes and hence the importance of our candidate gene lists for viral susceptibility case report studies in humans. Case report studies of COVID-19 represents an opportunity for researchers to identify the largest number of genes associated with severe viral infections in humans and to confirm previous case-report studies of viral susceptibility. It did not escape our notice that case-report studies are essential for us to discover rare genetic variants (low minor allele frequency) which are difficult to discover using GWAS studies which depend on statistical significance (common genetic variants).Accordingly, we believe that case report studies should go hand in hand with GWAS studies.

In table 2, we reviewed several GWAS case-control studies investigating the association of a specific gene locus with viral susceptibility to SARS-CoV and SARS-CoV-2. The philosophy of GWAS is that common diseases have common genetic variants in the general population that contribute partially to the pathogenesis of the disease in addition to different factors such as environmental factors or preexisting medical condition (Evangelou, 2018) .Unlike case report studies, GWAS usually aim to identify different genetic variants with different effect sizes and are not limited to a single gene as in the case of case-report studies of monogenic inborn errors of immunity.

In our case, severe COVID-19 affects a significant number of the population and different factors have been associated with severe manifestation,and it is time for GWAS to discover the role of common and rare variants -with different effect sizes-in the pathogenesis of the disease.

Accordingly, we invite GWAS investigators to widen their inclusion criteria to include all patients of different age groups to find common and rare variants associated with severe COVID-19. We predict that GWAS studies are more able to discover gene regulation elements involved in COVID-19 susceptibility more than case report studies because of the tendency to suspect genetic mutation with deleterious effect on proteins and neglect gene regulatory elements in case report studies as we can see on the IUIS list and also because of the wide use of WGS instead of WES in GWAS (Tangye et al., 2020) .

Different populations and different ethnic groups in the same population need separate GWAS studies due to different genetic backgrounds and SNPs frequencies variance (Huang et al., 2015) .We also recommend correction for confounders during study design and statistical analysis including acquired causes of immune deficiency, age, preexisting medical conditions and the sequence of the virus itself as a virulence factor (Wu and McGoogan, 2020) (Yoon et al., 2011) . Statistical significance is the backbone of GWAS studies, and we suggest that metaanalysis of different GWAS should be done on our candidate gene lists to accumulate evidence and report the significance from larger cohorts of patients from different populations with more statistical significance.

As of August 21, 2020, we found 5 studies (one of them is a preprint) associating COVID-19 severity with different genes as in table 2 (Ellinghaus et al., 2020; Kuo et al., 2020; Lu et al., 2020; Zhao et al., 2020) .

Three studies reported that ABO genes are associated with severity of COVID-19 disease and that blood group A individuals are more susceptible to risk of infection and severe manifestation while blood group O has a protective effect (Ellinghaus et al., 2020) . Interestingly, ABO genes were previously reported to be associated with several viral infections. West Nile virus infection is mostly asymptomatic, and manifestation occurs in only 20% of infected people. Symptomatic patients exhibited increased frequency of Blood group A (Kaidarova et al., 2016) . Additionally, ABO genes were associated with Rota virus and SARS-CoV infections (Pérez-Ortín et al., 2019) (Cheng et al., 2005) . In vitro studies revealed that regulates the localization of CD8 T memory cells within the lung to combat airway pathogens, while CCR9 acts as a key regulator in the early phases of allergic inflammation of the airway (Wein et al., 2019 ) (López-Pacheco et al., 2016 . Noteworthy, CCR1 is a flanking gene that is associated with inflammatory cascade and airway hyperresponsiveness in mice after infection by the respiratory syncytial virus and pneumovirus of mice (Bonville et al., 2004) . Functional antagonism of CCR1 results in improved survival of mice (Bonville et al., 2004) . We suggest CCR1 and CCR9 as a potential therapeutic target in COVID-19 patients which needs further investigations. Other associated genes with severe COVID-19 are described in Table 2 .

Elucidation of host genetic factors contributing to susceptibility to severe viral infection will help us understand the pathogenesis of severe viral infections in humans and facilitate genetic counseling conversation with index patients and their families (Patch and Middleton, 2018) .Possible treatment options for severely affected patients include treating them with the recombinant deficient factor (protein) as in case of Interferon-gamma treatment in deficient patients (Holland, 2001) . Vaccination of only genetically predisposed individuals during vaccine clinical trials with different treatments can remove a major confounding factor (inherent genetic susceptibility and resistance) (Glass et al., 2012) . Additionally, Vaccination can be reserved to those who are genetically predisposed to severe infections especially during early phases of production.

One case report study reported that 2 mutations in TLR3 ( D592N and M374T ) were not deleterious in vitro ) (Lim et al., 2014) , while another study reported the redundant effect of the mutations in 2 out of 12 patients' PBMCs (Zhang et al., 2007) , and hence adherence to strict guidelines for reporting a single gene to cause in inborn errors of immunity is essential .

GWAS studies are used to associate specific variants, e.g., SNPs, with a specific phenotype (e.g., We did not include animal models or cell culture studies that were not replicated in human patients due to lower evidence compared to case reports and GWAS studies. We also excluded studies of genes involved in conventional primary immunodeficiency and limited our focus to genes involved mainly in viral susceptibility to create a list of likely candidate genes responsible mainly for viral susceptibility in otherwise healthy individuals. Immune function is affected by acquired factors that play a major role in the immune response to different infections (Brodin et al., 2015) . We wanted, however, to focus on the role of the genetic origin of infection susceptibility. Hence, this review of host genetic susceptibility to viral infection is not the only factor to consider in understanding the pathogenesis of severe viral infections in humans including SARS-CoV-2.

In conclusion, our systematic review provides a detailed analysis of human genetic studies of susceptibility to severe viral infections in humans including case-report and case-control GWAS.

Our gene list represents a list of candidate genes that are likely to aid in explaining severe COVID-19 pathogenesis which are worthy of inclusion in gene panels during early J o u r n a l P r e -p r o o f implementation and late interpretation by meta-analysis of different variants from different GWAS.

Those genes are involved in multiple immunological pathways including TLR, C-lectin, and

Inflammasome pathways (NLRP1). We propose case report study method for discovering novel monogenic causes of severe viral disease in young healthy individuals without preexisting medical conditions (very low minor allele frequency that would prevent statistical significance in large population) and propose GWAS for the general population to discover common and rare genetic variants with different effects size associated with severe disease. We did not find case report studies on healthy young population between the age of 18 and 50. Hence, we invite researchers to widen their inclusion criteria to include this age group in case report studies as much of them are healthy without preexisting conditions to confound the genetic theory of susceptibility to severe COVID-19. ACE2 independent method of viral entry into human cells using DC-SIGN (lectin pathways) has been proven in vitro for SARS-CoV-2. We hypothesize that this might explain the recurrence of COVID-19 in some cases as HIV was proven to use the same DC-SIGN binding mechanism to remain latent in Dendritic cells for long periods.

Moreover, MxA gene promoter polymorphism was also associated with increased expression of the antiviral gene leading to decreased expression of viral proteins at the same time preventing complete immunological clearance of measles virus and predisposition to severe complication to subacute sclerosing panencephalitis. This also might explain latency and reactivation of COVID-19 in some cases. Whole-genome sequencing is essential for studying the polymorphisms in gene promoters and other regulatory genes such as regulatory RNA as these elements were underrepresented in our findings (only 2 promoters of genes MxA and OAS-1 out of 40 genes).

Some genetic mutations did not affect peripheral blood mononuclear cells production of interferon while it affected other cell lines inferring the redundant role of some genes in some cell lines and indicating the importance of studying different cell lines in vitro to characterize the mutation effect.

Up till now, 3 studies elucidated the effect of the ABO system on COVID-19 susceptibility to infection. The largest GWAS of COVID-19 host genetics revealed a significant signal at region 3p21.21 which contains SLC6A20 gene (interacts with ACE2), CXCR6 (regulates localization of CD8 T memory cell within the lung to combat airway pathogens) and CCR9 (a key regulator of early phases of allergic inflammation of the airway). Finally, CCR1 is a flanking gene to this J o u r n a l P r e -p r o o f region associated with inflammatory cascade and airway hyperresponsiveness in mice after infection with respiratory syncytial virus and pneumovirus of mice. We suggest CCR1, CCR9, IL-18 and EndoU(SARS-CoV-2 protein) inhibition as a potential therapeutic targets in COVID-19 patients that need further investigations. 

Severe viral respiratory infections in children with IFIH1 loss-of-function mutations

Inherited IL-18BP deficiency in human fulminant viral hepatitis

Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age

Functional Antagonism of Chemokine Receptor CCR1 Reduces Mortality in Acute Pneumovirus Infection In Vivo

Variation in the human immune system is largely driven by non-heritable influences

The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a chinese population

Guidelines for genetic studies in single patients: Lessons from primary immunodeficiencies

Herpes simplex virus encephalitis in human UNC-93B deficiency

Association of a single nucleotide polymorphism in the CD209 (DC-SIGN) promoter with SARS severity

ABO blood group and susceptibility to severe acute respiratory syndrome

Novel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2 Spike Protein to Host Lectins and Lung Microbiota

Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency

Coronavirus disease (COVID-19) Situation Report -205

An "Old" protein with a new story: Coronavirus endoribonuclease is important for evading host antiviral defenses

Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis

Genetic Epidemiology. Methods and Protocols

Targeting the NLRP3 Inflammasome in Severe COVID-19

Open-label, multicentre, dose-J o u r n a l P r e -p r o o f escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

Genes controlling vaccine responses and disease resistance to respiratory viral pathogens in cattle

Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies

Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity

Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors

Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population

Association of SARS susceptibility with single nucleic acid polymorphisms of OASI and MxA genes: A case-control study

Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Immunotherapy of mycobacterial infections

Genetic differences among ethnic groups

Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users

Blood group A and D negativity are associated with symptomatic West Nile virus infection

Toll-like receptor signaling pathways

Identification of small molecule inhibitors of Interleukin-18

APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort

DC-SIGNmediated internalization of HIV is required for trans-enhancement of T cell infection

Recurrent rhinovirus infections in a child with inherited MDA5 deficiency

Severe influenza pneumonitis in children with inherited TLR3 deficiency

TLR3 deficiency in herpes simplex encephalitis: High allelic heterogeneity and recurrence risk

Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients

Recurrence of COVID-19 after recovery: a case report from Italy

dengue hemorrhagic fever in Vietnam: Evidence of an association with variation in the vitamin D receptor and FCγ receptor IIA genes

CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation

Genetic risk factors for death with SARS-CoV-2 from the UK Biobank

Interferon-stimulated genes: A complex web of host defenses

Finding the missing heritability of complex diseases

PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels

DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus

Deletion of CCR1 Attenuates Pathophysiologic Responses during Respiratory Syncytial Virus Infection

Mutations in the TLR3 signaling pathway and beyond in adult patients with herpes simplex encephalitis

Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction

Genetic counselling in the era of genomic medicine

Histo-blood group antigens in children with symptomatic rotavirus infection

Human TRAF3 Adaptor Molecule Deficiency Leads to Impaired Toll-like Receptor 3 Response and Susceptibility to Herpes Simplex Encephalitis

Reactivation of COVID-19 pneumonia: A report of two cases

Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency

COVID-19 infection: the perspectives on immune responses

A Common Polymorphism in TLR3 Confers Natural Resistance to HIV-1 Infection

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis

Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee

The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic

Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis

Systems genetics: From GWAS to disease pathways

DC-SIGN: Escape mechanism for pathogens

Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors

CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

Comparative analysis of disease severity between genotypes IA and IIIA of hepatitis A virus

Influence of Fcγ RIIA and MBL polymorphisms on severe acute respiratory syndrome

Europe PMC Funders Group Meta-analysis in genome-wide association studies

Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection

Inborn Errors of RNA Lariat Metabolism in Humans with Brainstem Viral Infection

Relationship between the ABO Blood Group and the COVID-19 Susceptibility

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

 Table 2 of GWAS studies for SARS-CoV and SARS-COV-2 studies : overview of genes , genetic mutations , statistical significance , clinical manifestations and demographics involved in human viral immune response. Lu, C., Gam, R., Pandurangan, A.P., Gough, J., 2020. Genetic risk factors for death with SARS-